Genesco Inc. Files 8-K
Ticker: GCO · Form: 8-K · Filed: Jan 10, 2025 · CIK: 18498
| Field | Detail |
|---|---|
| Company | Genesco INC (GCO) |
| Form Type | 8-K |
| Filed Date | Jan 10, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $1.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-K
Related Tickers: GCO
TL;DR
Genesco filed a routine 8-K, no major news.
AI Summary
Genesco Inc. filed an 8-K on January 10, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements for this date.
Why It Matters
This 8-K filing indicates Genesco Inc. is meeting its regulatory reporting obligations with the SEC, but it does not disclose any new material events or financial information.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for reporting purposes and does not contain any new material information that would indicate increased risk.
Key Players & Entities
- Genesco Inc. (company) — Registrant
- January 10, 2025 (date) — Date of earliest event reported
- Tennessee (location) — State of Incorporation
- 615 367-7000 (phone_number) — Registrant's Telephone Number
FAQ
What is the primary purpose of this 8-K filing for Genesco Inc.?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to file Financial Statements and Exhibits as of January 10, 2025.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported in this filing is January 10, 2025.
In which state is Genesco Inc. incorporated?
Genesco Inc. is incorporated in Tennessee.
What is the principal executive office address of Genesco Inc.?
The principal executive office address of Genesco Inc. is 535 Marriott Drive, Nashville, Tennessee, 37214.
Does this filing disclose any specific financial results or material business changes?
This filing, as presented, does not disclose specific financial results or material business changes; it primarily serves as a reporting document for regulatory purposes.
Filing Stats: 477 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2025-01-10 16:20:07
Key Financial Figures
- $1.00 — nge on which registered Common Stock, $1.00 par value GCO New York Stock Exchan
Filing Documents
- gco-20250110.htm (8-K) — 42KB
- gco-ex99_1.htm (EX-99.1) — 31KB
- 0000950170-25-004174.txt ( ) — 186KB
- gco-20250110.xsd (EX-101.SCH) — 23KB
- gco-20250110_htm.xml (XML) — 4KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On January 10, 2025, Genesco Inc. issued a press release announcing comparable sales by retail segment and for the entire Company for the fourth fiscal quarter-to-date period ended December 28, 2024. The Company previously announced that management will make a presentation at the 2025 ICR Conference at 8:30am (Eastern time) on Monday, January 13, 2025. The audio portion of the presentation will be webcast live and may be accessed through the Company's internet website, http://www.genesco.com. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release issued by Genesco Inc. on January 10, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Genesco Inc. Date: January 10, 2025 By: /s/ Scott E. Becker Scott E. Becker Senior Vice President, Corporate Secretary and General Counsel